Cambridge police responded to a non-fatal shooting near MIT on Thursday evening where one person was non-fatally injured, the ...

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...

The biotech company plans to move into the new development in 2028, consolidating other leased and owned spaces in the ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its ...

Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty ...

Kendall Square Orchestra (K2O), a volunteer ensemble of musicians from Boston's world-renowned science and technology community, will present its fifth Symphony for Science, transforming Symphony Hall ...

Biogen (BIIB) announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year ...

It’s part of the world famous Kendall Square biotech hub, home to notable drugmakers like Moderna, Alnylam Pharmaceuticals and Sarepta Therapeutics. According to Biogen, the move centralizes the ...

The move centralizes Biogen’s presence in Kendall Square, integrating Biogen’s research and development and technical operations teams alongside its global and North American commercial ...